Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity
about
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesiclesComplement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibodyInteraction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanismsAntibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties.IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis.The importance of human FcgammaRI in mediating protection to malaria.Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptorsSuppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriersIgG3-antigen complexes are deposited on follicular dendritic cells in the presence of C1q and C3Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouseHuman immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritisCD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin toleranceAntibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine developmentProtective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection.Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.Antigen-capturing cells can masquerade as memory B cells.A role for complement in feedback enhancement of antibody responses by IgG3.The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapyA Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity.Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.Fc-receptors and immunity to malaria: from models to vaccines.B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice.Progress in the synthesis and biological evaluation of lipid A and its derivatives.Blimp-1-dependent and -independent natural antibody production by B-1 and B-1-derived plasma cells.Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice.Gain-of-function mutations in FcgammaRI of NOD mice: implications for the evolution of the Ig superfamily.Differential requirement of lipid rafts for FcγRIIA mediated effector activities.B-cells get the T-cells but antibodies get the worms.IgG subclasses determine pathways of anaphylaxis in mice.
P2860
2509c4ca3ed646264a91ac68b29faa5192c79bee61d78a612c38e4e646d6c75ecc3fd880ecf77d5184817e4fdde8cb7c984fb395b84ca4585a4b8f229f24092212c46e116553a75bb6adc6dd98f27d45a6ed65fc2a1588b5ae5fa74b692d0ec342a521f2a7bce2db95e58b554485c5a9569251020abaf889bce5682c3d759fcf9e287f58a3aaade40119ed1ed796af5e2980dc3eeb9aa747269749b331348c73ebb8ab68b5bb6c21304236cb8be5bf3052b2c6d7
P248
Q24655248-573D04E3-2CAC-4641-B04D-A67A0C888395Q24674255-5D0EAE87-72BF-4267-B319-881AF228031BQ27001177-5A782DAE-BC95-4F9B-BFB5-BC087AB2EF6DQ30530667-50DA9878-E0A6-4824-8101-0C75F7B27FEFQ31116360-7B1247E0-264E-4B85-9E17-CBED5992F74CQ33285037-60E4F463-D3C3-4D5B-928A-9FE0C6C40A49Q33562297-3C3C14BC-C454-4C4D-9B49-33483872175AQ33711883-0A546567-43F5-4FE7-9DF5-633151A151FCQ33819711-8E47F8F2-2BDF-4288-A127-B1C71792A40BQ33905591-06FCA4FC-2121-4547-A576-B6335B777557Q34003924-31DFB9D5-37B2-40D0-9BFF-9A4D69484EA3Q34004484-24059BDA-9D8D-4B1C-86CA-E083EA606CEBQ35685656-0446F6E6-8308-4F3B-BC75-D7F2BA7F7C99Q35689463-5BF561C0-3C74-4257-9C0C-ED0486A39447Q35834451-EE473BCD-AEB3-4B89-A98B-71DD8DE4A556Q35834623-7B729E10-A856-412E-B48F-72234A744B03Q35845957-911628C8-1E3D-472A-B0A9-D96C28F53712Q36228329-B5B4D116-5674-4CE4-AE24-D15CA36268D0Q36331649-517B08C0-A683-4B3E-BE29-2D847EDCD325Q36363223-61F09F37-8692-48B9-9ADB-B38FF8677253Q36368392-3279F72A-55E2-4128-939C-37A18817BA21Q36370424-632CA702-59B3-4773-B054-BE25DC35ABF8Q36371004-1EDA60D1-16F8-4B6D-9464-772587B9C289Q36402637-7E9DC571-7823-40E9-9D70-C8BDEFC6D0B5Q36604334-5F18143D-A37A-405D-8B76-E5DA35DEAEBFQ36758192-3EAECF61-B24F-4FA8-8C12-FDEDEDEF8DF5Q37178511-FFC90B6C-8302-447B-BD16-157E44F9C1F3Q37582419-92B1C73C-654B-4369-B204-48FE64C13A8EQ37713384-E40D03CF-772A-413D-B2A6-7A5F35774521Q39378325-2A7E4CCA-8192-4312-80AF-071BB0FC8A2FQ40139047-257A51B5-A5B8-4571-B1A1-F0B9106D868CQ40380529-398C568C-0288-4842-8EBC-E7AA742C8916Q41869942-686DBFB8-ADEE-4E7D-84DE-7825BFCDD30DQ42378643-F3D5A773-23FA-4F90-AD61-A8EB7AB4FBE9Q42758486-C1F6BCC0-C102-447E-A4EB-2E1AE66752F5Q47099530-42917590-5062-41A2-A71C-069635DBADD5
P2860
Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity
description
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Januar 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/01/01)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/01/01)
@nl
наукова стаття, опублікована в січні 1998
@uk
مقالة علمية (نشرت عام 1998)
@ar
name
Identification of the mouse Ig ...... n innate and adaptive immunity
@ast
Identification of the mouse Ig ...... n innate and adaptive immunity
@en
Identification of the mouse Ig ...... n innate and adaptive immunity
@nl
type
label
Identification of the mouse Ig ...... n innate and adaptive immunity
@ast
Identification of the mouse Ig ...... n innate and adaptive immunity
@en
Identification of the mouse Ig ...... n innate and adaptive immunity
@nl
prefLabel
Identification of the mouse Ig ...... n innate and adaptive immunity
@ast
Identification of the mouse Ig ...... n innate and adaptive immunity
@en
Identification of the mouse Ig ...... n innate and adaptive immunity
@nl
P2093
P921
P1476
Identification of the mouse Ig ...... n innate and adaptive immunity
@en
P2093
Dijstelbloem HM
Hogarth PM
P407
P577
1998-01-01T00:00:00Z